中文 | English
Return
Total: 778 , 1/78
Show Home Prev Next End page: GO
Author:(Hai-Lin LIU)

2.Lead compound optimization strategy (2)--structure optimization strategy for reducing toxicity risks in drug design.

Hai-Long LIU ; Jiang WANG ; Dai-Zong LIN ; Hong LIU

Acta Pharmaceutica Sinica 2014;49(1):1-15

7.Nuclear Factor Kappa B and Liver Injury

Hai LIN ; Zexin LI ; Jiangwei LIU ; Yongjiu ZHANG

Chinese Journal of Bases and Clinics in General Surgery 2003;0(06):-

9.Construction and application of storehouse for medical camp in emergency support brigade

Jiming ZHANG ; Cunhe LIN ; Ling WANG ; Hai YU ; Leihan LIU

Chinese Medical Equipment Journal 2004;0(09):-

10.Efficacy and safety of cladribine in treatment of patients with refractory/relapsed acute myeloid leukemia

Lijuan RU ; Hai LIN ; Yehui TAN ; Yanping YANG ; Shanshan LIU ; Xiangui LIU ; Wenjing LIU ; Sujun GAO

Journal of Leukemia & Lymphoma 2016;25(12):739-742

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 778 , 1/78 Show Home Prev Next End page: GO